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ABSTRACT 
AIM:  The study aimed to assess the effectiveness of flavored ice cubes on oral mucositis 
in patients with cancer receiving chemotherapy. BACKGROUND:  This study   evaluates the 
effect of application of flavored ice cubes in patients, on chemotherapy induced oral mucositis in 
combined chemotherapy regimens METHOD: The study consisted of total of 60 samples, 30 in 
experimental group and 30 in control group. Simple random sampling technique - lottery method 
was used to select samples. DESIGN:  The design adopted for the study was pre-test post test 
true experimental control group design. The experimental group was given flavored ice cubes to 
place in their mouth for 5 minutes before the chemo drug infusion, 30 minutes during the 
infusion and 5 minutes after the infusion of the chemodrug. The control group received no 
intervention.     Both the groups were treated with the following chemo drug combination (i) 
cisplatin + 5fu (ii) cisplatin + etoposide (iii) cisplatin + paclitaxel (iv) cisplatin + irinotecan (v) 
cisplatin + gemcitabine. The Oral Mucositis Assessment Scale was used for evaluation. 
RESULT: The results revealed that 70% of the samples in experimental group on pre test 
samples  had mild ulceration and 56% had not severe erythema. After application of ice cubes, 
on 3rd day observation 50% had no ulceration and 70% had no erythema and on 21st day 
observation 73.33% had no ulceration and 60% had no erythema. In control group, on pretest 
3.3% had mild ulceration, 60% had not severe erythema. On 3rd day observation 90% had mild 
ulceration, 96.6% had not severe erythema. On 21st day observation 70% had mild ulceration, 
93.33% had not severe erythema. 
In the pretest, majority of the samples in experimental group and control group had mild 
ulceration and not severe erythema. In the post test there was improvement in the reduction of 
oral mucositis in the experimental group whereas in the control group majority of the samples 
continued to have mild oral mucositis. There was an association between the oral mucositis and 
tobacco chewing, oral mucositis and the chemodrug usage. The combination of cisplatin+5fu and 
cisplatin+etoposide showed significant association in developing oral mucositis among the other 
chemodrug combinations enlisted. 
CONCLUSION: Oral cryotherapy makes an important contribution to the protection of oral 
health. Because of its easy of application, tolerability, and lack of side effects, has become  an 
important  remedy for reducing the incidence and severity of oral mucositis.   
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CHAPTER - I 
INTRODUCTION 
“Growth for the sake of growth is the ideology of the cancer cells” 
- Author unknown 
Human body is the most beautiful and generous creation of God. It has got the ability to 
adapt to the various situations provided, and vigorous climate conditions but sometimes, some 
conditions or factors, especially the ones resulting from the industrialization can harm it 
drastically and force it to death.  
A healthy cell does not turn into a cancer cell overnight. Richard, David and Faragher, 
described that  the first rule of cancers is that they follow no rules. Cancer cells exhibit dysplasia, 
hyperplasia, metaplasia, and pleomorphism. 
Cancer is a group of more than 200 diseases characterised by uncontrolled and 
unregulated  growth of cells. It is a major health problem that occurs in people of all ethnicities. 
Although cancer is often considered as disease of ageing, with the majority of cases diagnosed 
(76%) in over the age of 55 years it occurs in people of all ages. Globally cancers account for 
5.1% of total disease burden and 12.5% of all deaths. In India they account for 3.3% of disease 
burden and 9.9% of all deaths. With the increasing prevalence of tobacco and alcohol 
consumption in the country, it is estimated that 10 lakh new cases will be diagnosed in 2016, up 
from about 8 lakhs in 2001. Nearly 6,70,000 people are expected to die in the year 2016 due to 
cancer, in India.  (Chintamani and Lewis, 2011),   
According to  International Agency for Research on cancer,American Cancer soceity, 
(2011),  it was estimated that there were about 12.7 million new cancer cases and 7.6 million 
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cancer deaths in 2008 worldwide.  Overall incidence rates (per 100,000) for 1998-2002 among 
the 45 selected cancer registries worldwide vary by nearly 6-fold in men, from 86.3 in Algeria 
(Setif) to 453.3 in U.S. blacks, and by nearly 4-fold in women, from 80.3 in Algeria (Setif) to 
302.3 in U.S. non-Hispanic whites   By 2030, the global burden is expected to grow to 21.4 
million new cancer cases and 13.2 million cancer deaths simply due to the growth and aging of 
the population. 
    Maddireddy Umameshwar Rao Naidu, Gogula Venkat Ramana, Pingali Usha Rani, Iyyapu 
Krishna Mohan, Avula Suman, and Priyadarshni Roy, (2004)., described that, Chemotherapy and 
radiation therapy are the most widely used interventions for the treatment of cancer. Although 
these treatments are employed to improve the patient’s quality of life, they are associated with 
several side effects. Severe adverse reactions due to these therapies result in patient morbidity 
and mortality.  The major objective of cancer therapy is to treat the client with appropriate 
therapy for sufficient duration. So that the cure results with minimal functional and structural 
impairment. The goal of chemotherapy is to destroy as many tumor cells as possible with 
minimal effect on healthy cells. It can be used for cure, control, and palliation.  Chemotherapy 
induced side effects are the result of destruction of the normal cells, especially those that are 
rapidly proliferating such as those in the bone marrow, the lining of the GI system, and the 
integumentary system. There may be acute and delayed effects. 
The development of oral mucositis is a delayed effect of chemotherapy. Mucositis is the 
common side effect for cancer patients receiving chemotherapy and radiation therapy, and can 
occur anywhere along the digestive tract from mouth to the anus (Newton, Hicky and Mars 
2009). 
3 
 
 
 
Oral complications are frequent and troublesome symptoms for those undergoing 
chemotherapy for cancer. Several anti neoplastic agents are proved to have stomatotoxic 
potential, among them 5-FU, is found to have higher effect. (Djuric, Hillier-kolarov, Belic, 
Jankovic, 2006), 
According to mayoclinic.org, (2011), annually, there are approximately 4, 00,000 cases 
of treatment – induced damage to the oral cavity.  There are many types of chemotherapy that are 
known to cause oral mucositis. Some of these therapies are 5-fluorouracil, methotrexate, 
doxorubicin, etoposide, melphalan, cytosine arabinoside, cyclophosphamide, and cisplatin. 
      Witt, (2007) Oral mucositis is the debilitating symptom which can have a profound 
effect on the quality of life of a person diagnosed with cancer) Witt, (2007). Oral mucositis lead 
to pain which can become so severe that the patient is unable to eat or drink and can undermine 
the willingness to continue with chemotherapy.Douherty & Bailey, (2008). Oral mucositis can 
also lead to chemotherapy dose reductions, cessation of chemotherapy, hospitalisations, reliance 
on parenteral nutrition & even death Sonis (2007). 
  Rajesh lalla, Stephen sonis, Douglas Peterson, (2008), stated that, A wide variety of 
scales have been used to record the extent and severity of oral mucositis in clinical practice and 
research. The World Health Organization   scale is a simple, easy to use scale that is suitable for 
daily use in clinical practice. This scale combines both subjective and objective measures of oral 
mucositis. The National Cancer Institute   Common Terminology Criteria for Adverse Events   
version 3.0 includes separate subjective and objective scales for mucositis. The Oral Mucositis 
Assessment Scale (OMAS) is an objective scale, suitable for research purposes, that measures 
erythema and ulceration at nine different sites in the oral cavity. This scale has been validated in 
a multi-center trial with high inter-observer reproducibility and strong correlation of objective 
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mucositis scores with patient symptoms . The Eastern Cooperative Oncology Group  common 
toxicity criteria are also used in oncology trials to document severity of oral mucositis .  (Rajesh 
lalla, Stephen sonis, Douglas Peterson, 2008) 
According to Cancer Care, (2011), “Cold therapy” is a technique that nurses devised for 
people receiving the chemotherapy 5-FU. Starting five minutes before getting the drug and 
continuing for about half an hour, patients suck on ice chips. This closes the blood vessels in the 
mouth so that they are less affected by the drug as it goes through the bloodstream. (The 
damaging effects of 5-FU tend to drop off after half an hour). Studies show that people who use 
the ice chips have about half the amount of mouth sores and pain as people who do not use the 
ice chips. The technique has also been used with other types of chemotherapy. 
Nursing assessment and patient education will help alleviate the common and distressing 
symptom of oral mucositis. More research is needed to examine effective interventions, but 
healthcare professionals can rely oral care protocols to maintain patients’ functional status and 
quality of life. This evidence based practice will enhance quality and standards of nursing care 
given to the patient in the management of oral mucositis, and improves to the treatment 
compliance. 
NEED AND SIGNIFICANCE OF THE STUDY 
“Our food should be our medicine and our medicine should be our food.” 
                                                                                                                   ~ Hippocrates 
According to www.cancer.org, (2011), almost half of the people who are treated with 
chemotherapy and nearly everyone receiving head and neck radiotherapy or a Hematopoietic 
Stem Cell Transplant (HSCT) will get oral mucositis (OM).As well as the type of cancer being 
treated, the likelihood of developing oral mucositis varies depending on the situation, lifestyle 
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and medical history of the person. Those at particular risk are like young people and the elderly, 
those with previous oral health problems or oral mucositis, people who have poor oral hygiene 
during treatment, smokers, people who drink alcohol, diabetic patients, those receiving certain 
types of chemotherapy 
According to virtualmedicalcentre.com, (2010)., Oral mucositis is the initiation, 
inflammation and or ulceration of the mucosa. It is the commonest complications to almost all 
patients receiving radiation to head and neck and in significant patients receiving 5-FU. Oral 
mucositis is the complex problem involving not only the epithelial lining but also the other 
mucosal components, including the endothelial, extracellular matrix and connective tissue.  
  There are two types of mucositis, namely, direct mucositis and indirect mucositis. Direct 
mucositis is Maturity and cellular growth of epithelial cells, causing changes to the normal turn 
over and cell death. Indirect mucositis caused by the indirect invasion of gram-negative bacteria 
and fungal species. This usually happens when indirect stomatotoxicity appears. (Maddireddy 
Umameshwar Rao Naidu, Gogula Venkat Ramana, Pingali Usha Rani, Iyyapu Krishna Mohan, 
Avula Suman, and Priyadarshni Roy, 2004) 
According to www.nvydiamedical.com, (2013),  patients below 20 years are more likely to 
develop OM, as are those over age 50 years.  Patients with poor renal function, diabetes or 
HIV are more vulnerable, as are those with poor oral hygiene or existing oral problems. Patients 
who use tobacco or alcohol also are more vulnerable People being treated with the 
chemotherapeutic medications fluorouracil and cisplatin are most likely to develop OM (90% of 
cases).  
According to Poon & Sze-wan, (2012), oral mucositis is the common  adverse side effect 
caused by cancer treatment and can lead to mucosa toxicity. Patients with oral mucositis may 
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experience extreme pain and may not be able to eat, drink and talk. As a result their  quality of  
life is impaired. Nearly, 30 – 85 % of patients undergoing  chemotherapy would develop oral 
mucositis. 
Castelinoflavia (2011)., done a study which focused on the prevention of mucositis 
among cancer patients receiving 5-FU using plain vs flavored ice cubes to care their pain and 
improve their quality of life with fewer complications. The results showed that the flavored ice 
cubes were effective in preventing the oral mucositis and the patients were in favor of the 
flavored ice cubes. 
 
According to the Study conducted by ,  Lilleby ,Garcia, gooley, (2006)., in Fred 
Hutchinson Cancer Research Centre, 40 patients receiving high-dose melphalan followed by 
Peripheral Blood Stem Cell Transplantation   utilized cryotherapy or normal saline rinses before, 
during and after chemotherapy. Compared to the normal saline group, the patients who used 
cryotherapy had lower average National Cancer Institute   mucositis scores, a lower incidence of 
grades 3–4 mucositis, less use of narcotics and Total Parental Nutrition, and lower average 
patient-reported pain scores. Each of these differences was statistically significant. In addition, 
patient-reported activities of swallowing, eating, drinking, talking, sleeping and taste were less 
impaired in the cryotherapy group, and each of these differences was statistically significantly or 
suggestively different. These data support the hypothesis that cryotherapy reduces the severity 
and incidence of mucositis, with resulting clinical benefit in patients undergoing high-dose 
melphalan. 
   Evans, (2008), described that, The mucositis may affect the patient’s gum and dental condition, 
speech and self esteem are reduced further compromising patient’s response  to treatment and or 
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palliative care. scully, Epstein, sonis (2003)., described that mucositis also affects the survival 
because of the risk of infection and has a significant impact on quality of life and cost of care. 
Chemotherapy induced mucositis is generally limited to non-keratinised mucosa and most 
commonly involves the soft palate, ventrum of tongue /floor of the mouth, and buccal mucosa.  
“Oral cryotherapy, the therapeutic administration of cold is a prophylactic measures for 
oral inflammation.” The goal of chemotherapy is to destroy as many tumor cells as possible with 
minimal effect on healthy cells. But still, side effects like oral mucositis are unavoidable. Inorder 
to promote the patients well being and to prevent the malnourishment due to lack of tolerance, 
cryotherapy is preferred.  Considering the study support of oral cryotherapy for oral mucositis 
the researcher believed that this could bring positive effects on the patient’s health status. 
Preventing mucosal injury will pave better way for patients to cope up with chemotherapy and 
improve quality of life, hence researcher underwent this study. 
STATEMENT OF THE PROBLEM: 
An experimental study to evaluate the effectiveness of application of flavored ice cubes 
on oral mucositis among patients with cancer receiving chemotherapy in Devaki Cancer and 
Research Institute, Madurai. 
 OBJECTIVES OF THE STUDY: 
 To determine the level of oral mucositis among patients with cancer receiving 
chemotherapy in experimental group before and after using  flavored ice cubes. 
 To determine the pre and post test level of oral mucositis among patients with cancer 
receiving chemotherapy in control group. 
 To check the effectiveness of flavored ice cubes on oral mucositis among patients with 
cancer receiving chemotherapy. 
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 To find out the association between the pre test level of oral mucositis among patients 
receiving chemotherpay and selected demographic variable.(age, sex, education, 
occupation, habits of kutka, pan masala, betel nut, tobacco chewing, smoking, type of 
ancer and chemo drugs used). 
HYPOTHESES: 
 The mean post-test level of oral mucositis score among patients with cancer on 
chemotherapy who received the flavored ice cube will be significantly lower than their 
mean pre-test level of oral mucositis score in experimental group. 
 The mean post test level of oral mucositis score  in experimental group of patients with 
cancer on chemotherapy after receiving the flavored ice cubes will be significantly lesser 
than the mean post test score of patients  with cancer  on chemotherapy in control group. 
 There will be significant association between the pre test level of oral mucositis score 
with demographic variables(age, sex, education, occupation, habits of smoking, tobacco 
chewing, kutka, panmasala chewing,  type of cancer and  type of chemo drugs) 
DEFINITION OF TERMS: 
EFFECTIVENESS:  It refers to the change produced by an action or a cause. 
In this study, it refers to the outcome of flavored ice cube in reducing the oral mucositis 
among cancer patients receiving chemotherapy, which was measured by the score obtained by 
subjects in oral mucositis assessment scale (OMAS) 
FLAVORED ICE CUBES: It refers to ‘Trapezium prism’ shaped cubes of ice prepared in 
combination with milk and vanilla essence. The Ice cubes were freezed in the degree of -4degree 
celcius to -5 degree celcius for duration of minimum 8 hours to maximum 12 hours.  
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The trapezium prism shaped ice cube has an top and base rectangular shape. It has 1 
height (H), 2 length ( L1, L2 ), and two breadth ( B1 , B2 ). 
The size of the ice cube in centimeter is,  3.9(L1) * 3.6(L2) * 1.4(H) * 1.5 (B1)* 0.9(B2). 
ORAL MUCOSITIS: It refers to the inflammation of the oral mucous membrane as evidenced 
by the soreness, erythema, ulceration as determined by the oral mucositis assessment scale 
PATIENTS ON CHEMOTHERAPY: It refers to both male and female patients with cancer, 
receiving  chemotherapeutic agents Intravenously like Cisplatin +5FU, Cisplatin + Etoposide, 
Cisplatin + Paclitaxel, Cisplatin + Irinotecan, Cisplatin + Gemcitabine in Devaki Cancer and 
Research Institute, Madurai. 
ASSUMPTIONS: 
 Mucositis may compromise the nutritional status and quality of life of the cancer patients 
receiving chemotherapy. 
 The cooling of the oral mucosa using ice chips will reduce the blood flow to the oral 
mucosa, thus reducing the availability of chemotherapeutic agents to the oral mucosa. 
 Severity of oral mucositis may vary from individual to individual. 
DELIMITATIONS: 
 The study is delimited to patients with cancer receiving chemotherapy in selected 
hospitals at Madurai. 
  Application of ice cube in oral cavity were given only for the subjects who received 
chemo drug infusion  for the period of 3 days. 
PROJECTED OUTCOME: 
The study will reveal the level of oral mucositis while using flavored ice cubes, the 
results of the study will show there is or significant reduction in oral mucositis among cancer 
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patients using flavored ice cubes. The findings of the study will help the health professionals to 
give flavored ice cubes before, during and after the chemotherapy for patients with cancer. 
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CONCEPTUAL FRAMEWORK 
The study is based upon the J.W.KENNEY’S OPEN SYSTEM MODEL 
The main concepts of system model are input, throughput, and output  
INPUT  
Input refers to the matter, energy and the information that enters into the system through 
its boundary. 
In this study flavored ice cubes are applied in the oral mucosa, 5minutes before chemo 
drug infusion for 30 minutes and for 5minutes after chemo drug infusion. 
THROUGHPUT 
Throughput refers to the process where the system transforms energy, matter and 
information. 
In this study it refers to the effect of vasoconstriction which decreases the exposure of the 
chemo drug to the oral cavity mucous membranes. 
OUTPUT 
Output refers to the matter, energy and information that are processed. 
In this study it refers to the reduction in the level of oral mucositis after application of ice 
cubes in the oral mucosa, measured by Oral Mucositis Assessment Scale. 
FEEDBACK 
After processing the input, the system sends output (matter, energy and information) to 
the environment in altered state.  In this study it refers on the analysis of post test oral mucositis 
hence, when there is no reduction in the level of oral mucositis, then reassessment to be done 
from the assessment.  
  
12 
 
FIG 1: CONCEPTUAL FRAMEWORK BASED ON J.W. KENNEY’S OPEN SYSTEM MODEL 
 
 
 
 
 
 
 
 
 
 
 
ASSESSMENT OUTPUT INPUT THROUGHPUT
Demographic 
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chewing & 
smoking 
 Type of cancer 
 Chemo drugs 
used
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T 
Experimental 
Group
Application of Ice 
cubes to the oral 
mucosa of patients 
undergoing 
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minutes in prior, to 
chemo drug 
infusion for 30 
minutes during 
infusion and for 5 
minutes after 
infusion 
Control Group 
Vasoconstriction 
and reduction in 
absorption of 
chemo toxic agent 
to the oral mucosa  
No process  
P 
O 
S 
T 
T 
E 
S 
T 
Reduction in 
level of oral 
mucositis 
No reduction 
in the level of 
oral mucositis   No application of ice 
cubes 
FEEDBACK 
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CHAPTER - II 
REVIEW OF LITERATURE 
 According to Nancy Burns ( 2006) , the review of relevant literature is conducted to 
generate a picture of what is known about a particular situation and knowledge gaps that exist in 
it. 
 The Literature is classified under the following Headings: 
1. Literature related to incidence of oral mucositis  
2. Literature related to effects of oral mucositis 
3. Literature Related to Scales Measuring Oral Mucositis: 
4. Literature related to effectiveness of cryotherapy  
Incidence of oral Mucositis: 
 Sankaranarayanan and Boffetta in their Research on cancer prevention, detection and 
management in low- and medium-income countries , (2010), stated that cancer is no longer the 
burden of high income countries. In 1970, 15 % of newly reported cases were in low and middle 
income countries (LMIC), compared with 56% in 2008, expected to rise to 70% in 2030. Almost 
two thirds in 7.6 million annual cancer deaths worldwide occur in low income countries, making 
it leading cause of mortality. The inquiry of cancer care is farther demonstrated by the case 
fatality from cancer, which is 75% in low income countries, referring  to the fact that LMIC 
account for almost 80% of the burden of the disease due to cancer, yet receive only 5% of global 
resources devoted to deal with this emerging challenge. The congress decided to focus on 
primary prevention, screening and early detection, treatment and management, supportive care, 
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end of life as well as on how programme, infrastructures and resources are integrated into 
existing delivery system. 
    Oral mucositis is defined as mucositis of the oral and oropharyngeal mucous membranes 
and includes mucositis of the lips, tongue, gingiva, buccal mucosa, palate and floor of the mouth 
(Douherty & Bailey 2008). Oral mucositis, a condition characterised by inflammation and 
ulceration of the mouth with pseudomembrane formation, affects more than 40.0% of patients 
receiving chemotherapy and/or radiotherapy (Naidu, Ramana, Rani, Mohan, Suman & Roy 
2004; Volpato, Silva, Oliveira, Sakai & Machado 2007). 
  Oral mucositis is a significant problem in patients undergoing chemotherapeutic 
management for solid tumors. In one study, it was reported that 303 of 599 patients (51 %) 
receiving chemotherapy for solid tumors or lymphoma developed oral and/or GI mucositis. Oral 
mucositis developed in 22% of 1236 cycles of chemotherapy, GI mucositis in 7% of cycles and 
both oral and GI mucositis in 8% of cycles. An even higher percentage (approximately 75–80%) 
of patients who receive high-dose chemotherapy prior to hematopoietic cell transplantation 
develop clinically significant oral mucositis. (Rajeshlalla, sonis, Peterson, 2008) 
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Fig  : 1 – Level of Oral Mucositis 
 
Fig  2: Ulcerative oral mucositis of the labial mucosa and floor of the mouth, buccal 
mucosa, lateral and ventral surfaces of the tongue. 
Source : emedicine.medscape.com/article/1079570-clinical#a0217 ,(2013) 
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According to James Olimpio,(2008), Oral mucositis results in inflammatory cascade of  
complex interactive process that lead to painful break downs in the natural barrier state. 
Erythema, ulcerations, bleeding and breakdown of cellular and matriceal structures follow with 
the loss of the ability to prevent pathogenic bacteria from invading the mouth and, ultimately the 
blood stream in profoundly immuno suppressed patients. Toxic effects include painfull 
membranes with ulceration, inadequate nutrition from poor intake and absorption of nutrients, 
psychosocial distress, and potentially life threatening infection. 
Literature related to effects of oral mucositis 
According to news.cancerconnect.com (2014)., It is important that cancer patients be on 
the lookout for signs of mucositis, which should be treated as soon as possible once diagnosed. 
The consequences of mucositis can be mild, requiring little intervention, but they can also be 
severe--such as hypovolemia, electrolyte abnormalities, and malnutrition--and even result in 
fatality. Oral mucositis can: 
 Cause pain 
 Restrict oral intake 
 Act as a portal of entry for organisms 
 Contribute to interruption of therapy 
 Increase the use of antibiotics and narcotics 
 Increase the length of hospitalization 
 Increase the overall cost of treatment.  
Patients with oral mucositis and neutropenia (a type of white blood cell deficiency) have 
a relative risk of septicemia (a systemic, toxic illness caused by the invasion of the bloodstream 
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by virulent bacteria coming from a local infection) more than 4 times that of patients with 
neutropenia only. 
According to www.oralcancerfoundation.org, (2012)., Mucositis is further complicated 
by the nausea and vomiting that often occur with treatment. Chemotherapy and radiation therapy 
can affect the ability of cells to reproduce, slowing healing of the oral mucosa, often extending 
the duration of present mucositis. Patients with damaged oral mucosa and reduced immunity are 
also prone to mouth infections.Taste loss tends to increase in proportion to the aggressiveness of 
treatment. Nausea, pain, vomiting, diarrhea, a sore or dry mouth may make eating difficult. Thus, 
maintaining adequate nutrition is an important challenge for oral cancer patients. Reduction of 
caloric intake can lead to weight loss, loss in muscle mass strength and other complications, 
including a decrease in immunity and a longer healing time from treatments. 
 RajeshLalla, conducted a study in National institute of health, (2008)., the findings 
revealed that the oral mucositis can be very painful and can significantly affect nutritional intake, 
mouth care, and quality of life. For patients receiving high-dose chemotherapy prior to 
hematopoietic cell transplantation, oral mucositis has been reported to be the single most 
debilitating complication of transplantation. Infections associated with the oral mucositis lesions 
can cause life-threatening systemic sepsis during periods of profound immunosuppression . 
Moderate to severe oral mucositis has been correlated with systemic infection and transplant-
related mortality. In patients with hematologic malignancies receiving allogeneic hematopoietic 
cell transplantation, increased severity of oral mucositis was found to be significantly associated 
with an increased number of days requiring total parenteral nutrition and parenteral narcotic 
therapy, increased number of days with fever, incidence of significant infection, increased time 
in hospital and increased total inpatient charges . 
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  Saba Bashtawi , (2013), stated that oral mucositis has a serious impact on those who are 
undergoing cancer treatment. Brown, (2010)., described tha oral mucositis  the  affects the  
treatment schedule by delay or discontinued treatment, and  quality of life and aspects of daily 
living. Svanberg, (2007) stated that oral mucositis increases the possibility of the use of a 
nasogastric tube or total parenteral nutrition, the need for vascular access, and the use of Opioids. 
Rubenstein et al., (2004) stated that oral mucositis increases the length of hospital stay and 
consequently increases costs. Thus, OM represents a significant source of morbidity after 
chemotherapy and radiation therapy. 
According to Dent Clin North (2008), In patients receiving chemotherapy for solid 
tumors or lymphoma, the rate of infection during cycles with mucositis was more than twice that 
during cycles without mucositis and was directly proportional to the severity of mucositis . 
Infection-related deaths were also more common during cycles with both oral and GI mucositis. 
In addition, the average duration of hospitalization was significantly longer during chemotherapy 
cycles with mucositis. Importantly, a reduction in the next dose of chemotherapy was twice as 
common after cycles with mucositis than after cycles without mucositis . Thus, mucositis can be 
a dose-limiting toxicity of cancer chemotherapy with direct effects on patient survival. 
Literature Related to Scales Measuring Oral Mucositis: 
According to European Society for Medical Oncology (ESMO) clinical practice 
guidelines. A wide variety of scales have been used to record the extent and severity of oral 
mucositis in clinical practice and research. The World Health Organization (WHO) scale is a 
simple, easy to use scale that is suitable for daily use in clinical practice. This scale combines 
both subjective and objective measures of oral mucositis.The National Cancer Institute (NCI) 
Common Terminology Criteria for Adverse Events (CTCAE) version 3.0 includes separate 
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subjective and objective scales for mucositis .The Oral Mucositis Assessment Scale (OMAS) is 
an objective scale, suitable for research purposes, that measures erythema and ulceration at nine 
different sites in the oral cavity. This scale has been validated in a multi-center trial with high 
inter-observer reproducibility and strong correlation of objective mucositis scores with patient 
symptoms . The Eastern Cooperative Oncology Group (ECOG) common toxicity criteria are also 
used in oncology trials to document severity of oral mucositis. 
Literature related to effectiveness of cryotherapy  
Researchers from the Fred Hutchinson Cancer Research Center, (2006), recently 
conducted a clinical trial to evaluate the effectiveness of ice chips to prevent or reduce OM in 
patients treated with high doses of Alkeran. This trial included 40 patients with multiple 
myeloma. Twenty-one patients received ice chips (cryotherapy) 30 minutes prior to treatment 
and continued to use the ice chips for six hours. Nineteen patients received normal saline instead 
of ice chips. Severe OM occurred in 14% of patients treated with ice chips, compared with 74% 
of patients treated with saline.Individuals treated with ice chips received fewer narcotics and 
nutrition through a vein than those treated with saline. 
  Mahood, Dose, Loprinzi, (1991).conducted a study on oral mucositis, they described 
that, mucositis is a significant dose-limiting toxicity associated with fluorouracil (5FU), 
particularly when it is combined with leucovorin. They hypothesized that oral cryotherapy would 
cause local vasoconstriction and would temporarily decrease blood flow to the oral mucous 
membranes. If cryotherapy were used during the time of peak serum 5FU levels, then the oral 
mucous membranes would have less exposure to 5FU and thus develop less mucositis. To test 
this hypothesis, 95 patients scheduled to receive their first cycle of 5FU plus leucovorin were 
randomized to have oral cryotherapy at the time of chemotherapy administration or to serve as a 
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control group. Subsequent mucositis was significantly reduced in the group assigned to receive 
cryotherapy as judged by the attending physicians (P = .0002) and by the patients themselves (P 
= .0001). We now routinely recommend this cryotherapy procedure for our patients receiving 
daily bolus 5FU plus leucovorin 
Cryotherapy is the use of ice chips and ice cold water for the prevention of oral 
mucositis. Patients are to suck on ice and hold ice cold water in their mouth prior to, during and 
after rapid infusions of mucotoxic agents with a short half life. Cryotherapy is based on the 
theoretical and conceptual model of vasoconstriction decreasing exposure to the oral cavity 
mucous membranes to the mucotoxic agents.  (Rubenstein, Peterson, and Schubert, 2004). 
oral cryotherapy makes an important contribution to the protection of the oral health by 
reducing the mucositis score. In relevance to clinical practice, aggressive cancer therapy places 
patients at greater risk for oral complications and treatment related consequences. Oral 
cryotherapy, the therapeutic administration of cold, is a prophylactic measure for oral 
inflammation. The relevance for clinical practice will be understood the context of mucositis. 
The difference between the study and control group in terms of the change in PH values after 
chemotherapy was found to be statistically significant (p<0.05).  Sue Nikoletti ., (2005) 
  Mustafa Baydar, Dikilitas, Sevine, Senel and Aydogdu, (2005), conducted the study that 
investigated the effects of local cryotherapy on mucositis incidence administerd during 5-Fu 
treatment. Mucositis developed in 6.7% of the courses given with cryotherapy. In courses 
without cryotherapy, the ratio was 38.9%. Hence the study concluded that, cryotherapy was 
promising in preventing mucositits due to 5-Fu based chemotherapy regimens. 
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    Karagozoglu and Filiz Ulusoy, (2005), described  that  cryotherapy has effectively 
attenuate the onset and severity of mucositis in patients undergoing bolus chemotherapy with 5-
Fu and melphalan. 
Cryotherapy has been used to prevent or reduce oral mucositis in patients receiving bolus 
doses of 5-FU. Patients should place ice chips in the mouth 5 min before initiating chemotherapy 
and continue this procedure for about 30 min. It is believed that the decrease in oral mucosal 
temperature leads to local vasoconstriction, thereby, preventing the chemotherapeutic agent to 
reach the oral tissues in large quantities. This reduces the amount and severity of oral mucositis. 
Cryotherapy has also been shown to reduce oral mucositis when other chemotherapeutic agents 
with a short serum half-life like edatrexate are used. In this study, it was shown that only two out 
of 18 patients developed grade 2 or 3 mucositis compared to six out of seven controls. A recent 
clinical trial confirmed this finding in 22 patients who received high does chemotherapy had 
experienced grades 3 and 4 mucositis.  (  Megliorti,  Edwards and Schubert, 2006),   
The application of ice chips (cryotherapy) on the inflammed mucosa is based on the 
hypothesis that temporary local vasoconstriction of the oral mucosa vessels could reduce 
exposure of the replicating epithelium cells to peak levels of some cytostatic agents (Daniela 
alterio, 2007) 
 The Oncology Nursing Society Putting Evidence into Practice, (2007), team found that 
mucositis may be prevented with cryotherapy, the application of ice chips or ice-cold water to 
the oral cavity before, during, and after rapid infusions of mucotoxic agents. The literature 
supports cryotherapy for patients receiving bolus 5-fluorouracil (Multinational Association of 
Supportive Care in Cancer, 2005) and high-dose melphalan (Lilleby et al., 2006; Mori et al., 
2006). Cryotherapy is not to be used with agents that require patients to be careful with exposure 
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to cold (e.g., oxaliplatin), and other agents require further study. The optimal duration and 
intensity of cryotherapy are not established, but patients generally hold ice or ice-cold water in 
their mouths for at least five minutes before, during, and 30 minutes after treatment. 
 To conclude oral cryotherapy makes an important contribution to the protection of oral 
health.  Because of its case of application, tolerability, and lack of side effects makes it an 
important resource for reducing the incidence and severity of oral mucositis.  The role of 
oncology nurses is crucial to the application and success of oral cryotherapy.  
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CHAPTER - III 
RESEARCH METHODOLOGY 
RESEARCH APPROACH:  Quantitative approach was used for this study. 
Quantitative approach is the numeric information that is obtained from a formal measurement 
and is analysed statistically.( polit, 2011) 
RESEARCH DESIGN:           
True experimental Pre-test post-test control group design was adapted. 
An experimental design in which data are collected from subjects both before and after 
introducing intervention.(polit, 2011) 
Group Pretest Intervention Post test(3rd day) Post test(21st day) 
Experimental O1 X O2 O3 
Control O1 - O2 03 
 
Keys: 
O1 –   pre – test level of oral mucositis among experimental group and control group on 1st day  
O2 – post – test level of oral mucositis among experimental group and control group on 3rd                       
day 
O3 –  post – test level of oral mucositis among experimental group and control group on 21st day 
X  – administration of flavored ice cubes among experimental group   
 DEPENDENT VARIABLE: 
  Flavored ice cubes  
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INDEPENDANT VARIABLE: 
Oral  Mucositis 
RESEARCH SETTING:   
Study was conducted in  Devaki Cancer and Research Institute, Arasaradi, Madurai, 
which is  7.6  Km away from sacred heart nursing college.  This hospital provides all specialised 
care for all types of cancer and cancer patients on inpatient and out patient basis. The treatment 
includes  chemotherapy and radiation therapy -brachy therapy, and  tele therapy with the help of 
linear accelerator therapy .  
POPULATION:   
The target population of this study was patients with cancer  undergoing chemotherapy  
infusion  of cisplatin + 5Fu,cisplatin + etoposide, cisplatin +  paclitaxel ,cisplatin + irinotecan, 
cisplatin + gemcitabine,   for 3 days. 
SAMPLE:   
Patients with cancer receiving chemotherapy and who fulfills the inclusion criteria were 
the samples. 
SAMPLE SIZE:     
Total sample size was 60, among  whom, 30 in experimental group received application of  
flavored ice cubes, and  30 in control group received no intervention. 
SAMPLING TECHNIQUE:  
Simple random sampling – lottery method was used to allot the patients to experimental  
group and control group. 
 Lottery method is that, each member of the population is assigned to a unique number. 
The blind-folded researcher picks numbered tags from the bowl or hat that is mixed 
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thoroughly.all the individuals bearing the numbers picked by the researcher are the subjects for 
the study.( Suresh.k.sharma). 
CRITERIA FOR SAMPLE SELECTION 
INCLUSION CRITERIA 
 Patients with cancer  in agegroup of  20 -70 years 
 Patients with cancer who are undergoing chemodrug infusion  of  combinations like 
cisplatin + 5Fu,cisplatin + etoposide, cisplatin +  paclitaxel ,cisplatin + irinotecan, 
cisplatin + gemcitabine,   for 3 days. 
 Patients who had ulceration of score 1-18 and erythema of score 1-9.as per Oral 
mucositis Assessment Scale. 
 Both male and female patients with cancer 
 Those Who were willing to participate. 
EXCLUSION CRITERIA: 
 Patients  with cancer who underwent oral surgery  
 Patients with cancer having diabetes mellitus 
 Patients with  cancer who has severe oral mucositis  
RESEARCH TOOL AND TECHNIQUE  
The instrument used for the study has two parts  
Section I: Demographic profile  
It consists of demographic profile such as age, sex, education, occupation, habits of 
smoking, tobacco chewing, kutka and panmasala chewing. 
Section II: Clinical profile  
Type of cancer, chemo drugs used. 
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Section III:  
This part consists of oral mucositis assessment scale. It is standardized tool, downloaded 
from the internet The tool has nine items in it. The nine items will be assessed in two different 
criteria as  ulceration and erythema, each items were scored between 0, 1, 2 and 3  
In ulceration,  
0 refers to no ulceration, 
1 indicate < 1 cm, 
2 indicates ulcer size ranging from 1 – 3 cm, 
3 indicates ulcer above 3 cm. 
In erythema, 
0 refers to no erythema, 
1 refers to non-severe erythema, 
2 refers to severe erythema, 
Based on the scores obtained, the subjects will be grouped into various categories. 
The tool is annexed in appendix IV. 
Score between, 
In ulceration 
1 – 9 falls under mild ulceration, 
10 – 18 – moderate ulceration, 
19 – 27 – severe ulceration 
In erythema  
1 – 9 – not severe  
10 – 18 – severe erythema. 
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Intervention: 
Preparation of flavored ice cubes: 
Milk – 300 ml. 
Sugar -1 ½ table spoon 
Vanilla – 1 ½ tea spoon  
Freezing time – 8-12 hours  
Ice cubes were carried to the patient side using cool box.  
Intervention Rationale 
In this study, patients undergoing 3days chemo 
drug infusion for cancer at every 21 days 
interval are selected as the experimental group 
on the counts of  inclusion criteria and exclusion 
criteria. 
The oral mucositis of the patient was  assessed 
by oral mucositis assessment scale(OMAS 
scale) 
 The oral mucosa is examined on the first 
day of infusion. Before the infusion of 
infusion  of  combinations like cisplatin 
+ 5Fu,cisplatin + etoposide, cisplatin + 
paclitaxel ,cisplatin + irinotecan, 
cisplatin + gemcitabine,   for 3 days. 
   For experimental group Ice cubes are applied 
to every parts of the mouth for 20 – 30 minutes. 
After the chemodrug infusion, the patients were  
asked to do the same for 5 minutes. 
Development of oral mucositis is very rapid  in 
patients undergoing 3days infusion of chemo 
drug . 
 
 
It is a standard tool that helps to evaluate the 
extent of mucositis.  
 
Pre – test : evaluates the oral mucosal status 
 
 
 
 
 
 
Inorder that every part of the Cryotherapy 
reduces the amount of drug reaching the 
oral mucous membrane and may therefore 
reduces the mucositis caused by the cytotoxic 
effects of the drugs.  
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 After completion of one ice cube it will be 
replaced by the other. 
Post test was done on 3rd day and 21st day of the 
chemo cycle using oral mucositis assessment 
scale. 
Maintains the constancy of coolness within the 
mouth. 
Helps to know the effectiveness of oral 
cryotherapy in reduction of oral mucositis.  
 
TESTING OF THE TOOLS: 
Validity: 
The validity of the tool and intervention was obtained by giving  it to seven experts, two   
Medical oncologists and four  Medical surgical nursing experts and one  Bio-statistician. Based 
on their valid suggestions reframing of the intervention was done. 
Reliability:  
Oral mucositis assessment scale demonstrated a good reliability of 0.88 on the inter rater 
method. 
Pilot study: 
Among six patients each three were assigned to experimental group and control group. 
Data were analysed and findings revealed that the study was feasible. 
Data collection procedure: 
Formal permission was obtained to conduct the study from the clinical oncologist in 
Devaki  Cancer and Research Institute, Madurai  and from the ethical committee of Sacred Heart 
Nursing College, Madurai .The researcher introduced to the selected sample &the verbal consent 
obtained from each subject after giving assurance of confidentiality. The period of study 
extended for 6weeks.The data was collected from Monday –Saturday. The samples were selected 
according to the criteria laid down. 
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Monday – Saturday (9a.m to 5 p.m) 
Pre test (Day 1) & Post test – I (Day 3) Post test - II (Day 21) 
Weeks I II III IV V VI 
Groups  
14 
 
9 
 
7 
 
14 
 
9 
 
7 Experimental  
Control 10 12 8 10 12 8 
 On day-1 the samples who had mild to moderate level of oral mucositis  score ,and 
patients who fulfilled the inclusion &exclusion criteria  were allowed for application of ice 
cubes. The ice cubes were made by the mixture of water, milk, sugar &vanilla essence ( to add 
color  & flavor). The application of ice cubes had been started by the researcher 5 minutes prior 
to the chemo drug infusion and continued for 30 minutes  and 5 minutes after the chemo drug  
infusion for 3 days .These steps were followed in all the samples ,  under  experimental group 
.The samples co-operated well , and participated actively in the study. 
At the end of 3rd day of chemo drug infusion and on 21st day of return of next chemocycle 
the oral mucositis was assessed and scored, using Oral Mucositis  Assessment Scale. 
In control group the level of oral mucositis was assessed using oral mucositis assessment 
scale   1st ,2nd and 3rd day of the chemocycle.  The control group underwent their treatment 
regimen with no intervention of oral cryotherpay. 
Plan for data analysis:   
The data analysis of the study of the study was done according to the objectives of the 
study by using inferential and descriptive statistics. 
Descriptive statistics: 
Frequency, percentage and mean were used for the analysis of level of oral mucositis. 
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Inferential statistics: 
Paired ‘t’ test were used to determine  between the prettest  and post test in terms of the 
effectiveness of application of ice cubes in experimental group. 
Independent ‘t’test was used to determine the difference between the post-test of 
experimental group and control group in terms of effectiveness of application of ice cubes. 
Chi square was used to determine the association between selected demographic variables. 
Protection of human rights: 
 Research proposal was approved by dissertation committee of Sacred heart Nursing 
College, Madurai.  Permission was obtained from  Devaki Cancer and Research Institute, 
Madurai, prior to the study.  Oral consent of each study subject was obtained before starting data 
collection.  Assurance was given to the subjects, that confidentiality was maintained.  The 
subjects were explained that they have rights to withdraw from the study.  There was absence of 
physical and psychological strain to study subjects. 
  
  
31 
 
CHAPTER – IV 
ANALYSIS AND INTERPRETATION OF DATA 
This chapter deals with the description of samples, classification, analysis, and 
interpretation of data collected to evaluate the achievement of the objectives of the study 
and discussion of the study findings, the data is tabulated and described as follows. 
Presentation of the findings of the study  
Section 1:   
1. Frequency and distribution of subjects with regard to the selected demographic 
variables. 
2. Frequency and percentage distribution of the subject with regard to selected 
clinical variables. 
Section 2:  
3. Distribution of subjects according to the level of mucositis before and after 
application of ice cubes in experimental group 
4. Distribution of subjects according to the level of mucositis in control group 
5. Distribution of subjects according to the post test level of oral mucositis in 
experimental group and control group 
Section 3: 
6. Comparison of mean pre test and post test level of oral mucositis in experimental 
group on day 3 
7. Comparison of mean pre test an post test level of oral mucositis among the 
patients receiving chemotherapy after the application of flavored ice cubes in 
experimental group on day 21. 
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8. Comparison of mean post test of oral mucositis on day 3 and on day 21 in the 
experimental group  
9. Comparison of mean pre test and post test (day 21) level of oral mucositis in 
control group 
10. Comparison of mean post test level of oral mucositis of the experimental group an 
control group on day 3. 
11. Comparison of mean post test level of oral mucositis of the experimental group an 
control group on day 21. 
Section 4:  
12. Association between the levels of oral mucositis of experimental group and 
control group before the use of flavored ice cubes with demographic variables.  
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SECTION – I 
DEMOGRAHIC VARIABLES OF THE SAMPLES 
 This section deals with the demographic variables of the subjects such as age, sex, 
education status, occupation, type of cancer, habits of tobacco chewing, pan, kutka, 
smoking, and betel nut chewing. 
Table 1: Frequency and distribution of subjects with regard to the selected 
demographic variables 
 
Demographic 
Characteristics 
Experimental Group 
n = 30 
Control Group 
 n = 30 
Total 
N= 60 
F % F % F % 
Age: (in years) 
 20 – 30 years 
 31 – 40 years 
 41 – 50 years 
 51 – 60 years 
 61 – 70 years 
Sex: 
 Male 
 Female 
Education: 
 Primary 
 Secondary 
 Higher Secondary 
 Illiterate  
Occupation: 
 Employed 
 Unemployed 
 
2 
7 
5 
11 
5 
 
21 
9 
 
9 
6 
5 
10 
 
20 
10 
 
6.66 
23.33 
16.67 
36.67 
16.66 
 
70 
30 
 
30 
20 
16.6 
33.33 
 
66.66 
33.33 
 
2 
5 
6 
10 
7 
 
16 
14 
 
6 
11 
1 
12 
 
22 
8 
 
6.66 
16.66 
20 
33.33 
23.33 
 
53.33 
46.66 
 
20 
36.66 
3.33 
40 
 
73.33 
26.67 
 
4 
12 
11 
21 
12 
 
37 
23 
 
15 
7 
6 
22 
 
42 
18 
 
6.66 
20 
18.33 
35 
20 
 
61.66 
38.33 
 
25 
28.33 
10 
36.66 
 
70 
30 
          Table cont… 
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Demographic 
Characteristics 
Experimental Group 
n = 30 
Control Group 
n = 30 
Total 
N= 60 
F % F % F % 
Habits of tobacco chewing: 
 Yes 
 No 
Habit of betel nut 
chewing: 
 Yes 
 No 
Habit of Smoking: 
 Yes 
 No 
Habit of Kutka: 
 Yes 
 No 
 
3 
27 
 
 
2 
28 
 
13 
17 
 
0 
0 
 
10 
90 
 
 
6.66 
93.33 
 
43.33 
56.66 
 
0 
0 
 
1 
29 
 
 
1 
29 
 
11 
19 
 
0 
0 
 
3.33 
96.6 
 
 
3.33 
96.6 
 
36.66 
63.33 
 
0 
0 
 
4 
56 
 
 
3 
57 
 
24 
36 
 
0 
0 
 
6.66 
93.33 
 
 
5 
95 
 
40 
60 
 
0 
0 
Habit of Pan: 
 Yes 
 No 
 
2 
28 
 
6.66 
93.33 
 
 
1 
29 
 
3.33 
96.6 
 
3 
57 
 
5 
95 
 
 With regard to age, both in experimental group and  control group majority of 
samples were between 51-60 years ,11(36.67%) and 10(33.33%) respectively.  
 Regarding sex, in both experimental group and control group the majority of the 
samples were males. 21(70%) and 16(53.33%) respectively. 
 With regard to education both in experimental group and control group the 
majority of the samples were illiterate 10(33.33%) and 12 (40%) respectively. 
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 Wit regard to occupation both in experimental group and control group the 
majority of the samples were employed 20(66.66%) and 22(73.33%) respectively. 
 Regarding the smoking habits 13(43.33%)of the samples in experimental group   
and 11(36.66%)of samples in control group had habit of smoking. 
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FIG 4: Pie diagram showing habits of samples on usage of tobacco, betelnut, kutka, pan 
masala chewing and smoking in experimental group. 
 
FIG 5: Pie diagram showing habits of samples on usage of tobacco, betelnut, kutka, pan 
masala chewing and smoking in control group. 
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Clinical Profile of the samples 
This section deals with the clinical variables of the subjects. 
Table 2: Frequency and percentage distribution of the subject with regard to selected 
clinical variables.  
Demographic 
Characteristics 
Experimental Group 
n = 30 
Control Group 
n = 30 
Total 
N= 60 
F % F % F % 
Type of Cancer: 
 Lung Cancer 
 Stomach Cancer 
 Cervical Cancer 
 Colon Cancer 
 Rectal Cancer 
 Overian Cancer 
 Cricoid Cancer 
 Hodgkins 
Lymphoma 
 Cancer Skin 
 Ca nasopharynx 
 Ca Supraglottis 
 Ca larynx 
Drugs Used: 
 Cisplatin + 5FU 
 Cisplatin + etoposide 
 Others* 
 
8 
5 
7 
0 
1 
2 
2 
1 
 
1 
1 
0 
2 
 
7 
16 
7 
 
26.66 
16.66 
23.33 
0 
3.33 
6.66 
6.66 
3.33 
 
3.33 
3.33 
0 
6.66 
 
23.3 
53.3 
23.3 
 
9 
5 
8 
1 
2 
3 
0 
1 
 
0 
0 
1 
0 
 
17 
6 
7 
 
30 
6.66 
20 
3.33 
6.66 
10 
0 
3.33 
 
0 
0 
3.33 
0 
 
56.7 
20.0 
23.3 
 
17 
7 
13 
1 
3 
5 
2 
1 
 
1 
1 
1 
2 
 
24 
22 
14 
 
28.33 
11.66 
43.33 
1.66 
5 
8.33 
3.33 
1.66 
 
1.66 
1.66 
1.66 
3.33 
 
80 
73.3 
46.6 
 
Regarding the type of cancer among experimental group 8(26.66%) were 
suffering with lung cancer and in control group 9(30%) were having lung cancer. 
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Regarding the usage of drug in experimental group 16(53.3%) of samples were 
treated with cisplatin+etoposide and in control group 17(56.7%) of samples were treated 
with cisplatin and 5fu combination. 
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FIG 6: Pie diagram showing chemodrug usage among the experimental group with regard 
to selected demographic variables 
 
 
FIG7: Pie diagram showing chemodrug usage among the control group with regard to 
selected demographic variables 
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SECTION – 2 
DISTRIBUTION OF SAMPLE ACCORDING TO THE LEVEL OF MUCOSITIS 
Table 3: Distribution of subjects according to the level of mucositis before and after 
application of ice cubes in experimental group. 
Level of Mucositis Pre  Test Post Test 
F % F (3rd day) % F (21st day) % 
Ulceration: 
 No ulcer 
 Mild 
Erythema: 
 No erythema  
 Not severe 
 
9 
21 
 
4 
26 
 
30 
70 
 
13.3 
86.66 
 
15 
15 
 
21 
9 
 
50 
50 
 
70 
30 
 
22 
8 
 
18 
12 
 
73.33 
26.6 
 
60 
40 
Data on table 3 are based on the level of mucositis obtained. The subjects were 
classified into 4 groups. No ulcer (0), mild (1-9), moderate (10-18), severe (18-30). 
In experimental group Before using of application of flavored ice cubes client 9 
samples(30%) had no ulcer and   21(70%) had mild ulceration. After application of ice 
cubes on 3rd day observation 15 (50%) had no ulceration and 15 (50%) had mild 
ulceration on 21st day observation in   22 (73.33%) had no ulceration and 8 (26.6%) had 
mild ulceration. 
Regarding erythema 4(13.3%) of samples had no erythema and 26 (86.66%) had 
erythema of not severe category in pre test.  After application of ice cubes on 3rd day 
21(70%) had no erythema and 9(30%) had not severe erythema and on 21st day 18 
(60%)of samples had no erythema and 12 (40%)of samples had not severe erythema. This 
difference may be due to application of ice cubes. 
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FIG 8 : Distribution of subjects according to the level of mucositis – ulceration  in 
experimental group. 
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FIG 9: Distribution of samples according to the level of oral mucositis – erythema  in 
experimental group. 
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Table 4: Distribution of subjects according to the level of mucositis in control group 
Level of Mucositis Pre  Test Post Test 
F % F (3rd day) % F (21st day) % 
Ulceration: 
 No ulcer 
 Mild 
Erythema: 
 No erythema  
 Not severe 
 
8 
22 
 
12 
18 
 
26.66 
73.3 
 
40 
60 
 
3 
27 
 
1 
29 
 
10 
90 
 
3.33 
96.66 
 
9 
21 
 
2 
28 
 
30 
70 
 
6.66 
93.33 
 
Table 4 shows that 8(26.66%) of samples had no ulceration and 22(73.3%) had 
mild ulceration.  On 3rd day observation 3 (10%) had no ulceration and 27 (90%) had 
mild ulceration on 21st day observation 9(30%) had no ulceration and 21(70%) had mild 
ulceration. 
For erythema 12(40%) had no erythema and 18(60%) had not severe erythema 
and on 3rd day observation 1(3.33%) had no erythema and 29(96.66%) had not severe 
erythema and on 21st day observation 2(6.66%) had no erythema and 28 (93.33%) had 
not severe erythema. 
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 FIG 10: Distribution of subjects according to the level of mucositis – ulceration in 
control group 
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 FIG 11: Distribution of subjects according to the level of mucositis – erythema  in 
control group 
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Table 5: Distribution of subjects according to the post test level of oral mucositis in 
experimental group and control group. 
Level of Mucositis Experimental Group 
N = 30 
Control Group 
N = 30 
3rd day 21st day 3rd day 21st day 
F % F % F % F % 
Ulceration: 
 No Ulcer 
 Mild 
 Moderate 
 Severe 
Erythema: 
 No erythema 
 Not severe 
 
15 
15 
- 
- 
 
21 
 
9 
 
50 
50 
- 
- 
 
70 
 
30 
 
22 
8 
- 
- 
 
18 
 
12 
 
73.33 
26.66 
- 
- 
 
60 
 
40 
 
 
3 
27 
- 
- 
 
1 
 
29 
 
10 
90 
- 
- 
 
3.33 
 
96.66 
 
9 
21 
- 
- 
 
2 
 
28 
 
30 
70 
- 
- 
 
6.66 
 
93.33 
* significant  at 0.05 level. 
Table 5 shows that in experimental group the 15(50%) of samples had n 
ulceration on 3rd day observation and on 21st day 22(73.33%) had no ulceration in control 
group on 3rd day (3)10% had no ulceration and 27(90%) had mild ulceration.  On 21st day 
9(30%) had no ulceration and 21(70%) had mild ulceration. 
 Regarding erythema in experimental group on 3rd day 21(70%) had no erythema 
and 9(30%) had not severe erythema and on 21st day observation 18(60%) had no 
erythema and 12(40%) had not severe erythema.  In control group on 3rd day observation 
1(3.33%) had no erythema and 29(96.6%) had not severe erythema.  On 21st day 
2(6.66%) had no erythema and 28(93.33%) had no severe erythema. 
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FIG 12: Distribution of subjects according to the post test level of oral mucositis on day 
21 in experimental group and control group. 
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FIG 13: Distribution of subjects according to the post test level of oral mucositis on day 
21 in experimental group and control group. 
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SECTION – 3 
Table 6: Comparison of mean pre test and post test level of oral mucositis in 
experimental group on day 3. 
Measurement N Mean SD T-test Df  
Pre test 
 
Post test   
30 
 
30 
2.76 
 
1.13 
3.10 
 
1.64 
 
5.67* 
 
29 
* Significant at 0.05 level. 
 Table 6 shows that on 3rd day observation in experimental group the mean pre test 
score is 2.76 and the mean post test (3rd day) score is 1.13.  The ‘t’ value for 3rd day 
observation is 5.67 is statistically significant at 0.05 level. This indicates that the mean 
difference of 1.63 score of oral mucositis is a true difference and has not occurred by 
chance. 
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FIG 14 : Comparison of mean pre test and post test level of oral mucositis in 
experimental group on day 3 
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Table 7: Comparison of mean pre test and post test level of oral mucositis among 
the patients receiving chemotherapy after the application of flavored ice cubes in 
experimental group on day 21. 
Measurement N Mean SD T-test Df  
Pre test 
 
Post test   
30 
 
30 
2.76 
 
0.76 
3.10 
 
0.83 
 
4.2* 
 
29 
* Significant at the level of 0.05. 
  To find out if there is any difference between the mean mucositis score before 
and after application of flavored ice cubes, the null hypothesis was stated as follows. 
H01: the mean post test level of oral mucositis score among the patients with cancer 
receiving chemotherapy who received application of flavored ice cubes will not be 
significantly lower than their mean pre test level of mucositis score in experimental 
group. 
Table 8 shows that, the mean post test score (0.76) of level of mucositis after application 
of flavored ice cubes was lower than the mean pre test score of (2.76). the obtained ‘t’ 
value of 4.2 at df 29 was significant at the level of 0.05. This indicates that the difference 
in mean is betterment of oral mucositis status of the samples. So, the researcher rejets the 
null hypothesis and accepts the research hypothesis. 
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FIG 15: Comparison of mean pre test and post test level of oral mucositis in 
experimental group on day 21 
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Table 8: Comparison of mean post test level of oral mucositis on day 3 and on day 
21 in the experimental group. 
Measurement N Mean SD T-test Df 
Level of oral mucositis on day 3 
 
Level of oral mucositis on day 21 
30 
 
30 
1.13 
 
0.76 
1.64 
 
0.83 
 
2.91* 
 
29 
 
 Table 8 shows that the mean mucositis score of experimental group on 3rd day 
was 1.13 and the mean score on 21st day is 0.76. The t-value is 2.91 is statistically 
significant at 0.05 level. This indicates that the mean difference of 0.37 score of oral 
mucositis is a true difference and has not occurred by chance. 
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FIG 16: comparison of mean post test level of oral mucositis on day 3 and on day 21 in 
the experimental group. 
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Table 9: comparison of mean pre test level of oral mucositis and mean post test level 
of oral mucositis in control group. 
Measurement N Mean SD T-test Df 
Pre test  
 
Post test day 21 
30 
 
30 
2.63 
 
2.36 
2.15 
 
1.66 
 
4.23* 
 
29 
* Significant at the level of 0.05. 
Table 9 shows that on 1st day observation in control group the mean pre test score 
is  2.63 and the mean post test (21st day) score is  2.36.  The ‘t’ value for  21st day 
observation is  4.23 is statistically significant at 0.05 level. This indicates that the mean 
difference of  0.33 score of oral mucositis is a true difference and has not occurred by 
chance. 
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Table 10: Comparison of mean post test level of oral mucositis of the experimental 
group and control group on day 3. 
Measurement N Mean SD T-test Df 
Experimental Group 
 
Control Group 
30 
 
30 
1.13 
 
3.8 
1.64 
 
2.03 
 
8.6* 
 
29 
 
 The table 10 shows that the mean mucositis score on day 1 was 1.13 and score on 
day 3 was 3.8.  The t-value is 8.6 is statistically significant at 0.05 level. This indicates 
that the mean difference of 2.67 score of oral mucositis is a true difference and has not 
occurred by chance.  
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FIG 17: Comparison of mean post test level of oral mucositis of the experimental group 
and control group on day 3 
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Table 11: Comparison of mean post test level of mucositis of experimental group 
and control group on day 21. 
Measurement N Mean SD T-test Df  
Experimental Group 
 
Control Group 
30 
 
30 
0.76 
 
 2.36 
0.83 
 
1.66 
 
 5.4* 
 
58 
* significant at the level of 0.05 level. 
To find out if there is any difference between the mean post test level of oral 
mucositis score between the experimental group and control group, the null hypothesis 
was stated as follows 
H02: The mean post test level of oral mucositis score in experimental group of 
patients with cancer receiving chemotherapy will not be significantly lesser than the 
mean post test score of patients with cancer receiving chemotherapy in control group. 
Table 11 shows that the mean post test score of oral mucositis in experimental group 
(0.76) was lesser than the mean post test score of control group(2.36). The obtained ‘t’ 
value 5.4 of df  58 is significant at 0.05 level. This difference between the mean(1.16), is 
a true difference and has not occurred by chance. So, it can be inferred that application of 
flavored ice cubes has a significant role in improving the mucositis status. So, the 
researcher rejects the null hypothesis and accepts the research hypothesis. 
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FIG 18 : Comparison of mean post test level of oral mucositis of the experimental group 
and control group on day 21 
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SECTION – 4 
Table 12: Association between the levels of mucositis of experimental and control 
group before the use of flavored ICE cubes with demographic variables 
Variables Above Mean Below Mean χ2 Df 
Age: (in years) 
 20 – 30 years 
 31 – 40 years 
 41 – 50 years 
 51 – 60 years 
 61 – 70 years 
Sex: 
 Male 
 Female 
Education: 
 Primary 
 Secondary 
 Higher Secondary 
 Illiterate  
Occupation: 
 Employed 
 Unemployed 
Type of Cancer: 
 Lung Cancer 
 Stomach Cancer 
 Cervical Cancer 
 Colon Cancer 
 Rectal Cancer 
 Overian Cancer 
 Cricoid Cancer 
 
1 
8 
5 
12 
4 
 
18 
12 
 
8 
11 
2 
11 
 
23 
7 
 
7 
5 
7 
8 
1 
1 
2 
 
3 
4 
6 
9 
8 
 
19 
11 
 
7 
6 
4 
11 
 
19 
11 
 
10 
5 
7 
0 
2 
3 
0 
 
 
 
4.186# 
 
 
 
0.070# 
 
 
1.91# 
 
 
 
 
1.270# 
 
 
 
 
 
 
7.3# 
 
 
 
 
4 
 
 
 
1 
 
 
3 
 
 
 
 
1 
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Table cont…
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    Variables 
Above Mean Below Mean χ2 Df 
 Hodgkins 
Lymphoma 
 Cancer Skin 
 Ca nasopharynx 
 Ca Supraglottis 
 Ca larynx 
Habits of tobacco chewing: 
 Yes 
 No 
Habit of betel nut 
chewing: 
 Yes 
 No 
Habit of Smoking: 
 Yes 
 No 
Habit of Kutka: 
 Yes 
 No 
Habit of Pan: 
 Yes 
 No 
Drugs used: 
 Cisplatin + 5FU 
 Cisplatin + etoposide 
 Others* 
1 
 
1 
1 
0 
1 
 
2 
27 
 
 
2 
27 
 
11 
19 
 
0 
0 
 
2 
27 
 
7 
16 
7 
1 
 
 
0 
1 
1 
 
2 
29 
 
 
1 
30 
 
13 
17 
 
0 
0 
 
1 
30 
 
17 
6 
7 
 
 
 
 
 
 
 
 
8.722* 
 
 
 
0.42# 
 
 
0.27# 
 
 
0# 
 
 
0.38# 
 
 
 
8.712* 
 
 
 
 
 
 
 
1 
 
 
 
1 
 
 
1 
 
 
1 
 
 
1 
 
 
 
2 
 
* Significant at 0.05 level      # not significant at 0.05 level. 
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To find out if there is any association between oral mucositis score of subjects and 
the selected demographic variables of age, sex, education, occupation, habits of pan 
masala, tobacco, betel nut, kutka chewing, smoking, type of cancer, chemodrugs used 
H03: There will be no significant association between the pre test level of oral 
mucositis score and demographic variables of age, sex, education, occupation, habits of 
pan masala, tobacco, betel nut, kutka chewing, smoking, type of cancer, chemodrugs 
used.  . 
Inorder to find out the association between the oral mucositis score and selected 
demographic variables chi square  test was computed. 
 Regarding the  association between the mucositis score and Age, the obtained  
chi-square value of  4.186 at df  4 (9.49)was not significant at p(<0.05)level. 
Regarding mucositis score and sex the chi-square value of 0.70 at df (1)p(<0.05) 
shows no significance. 
Regarding mucositis score and education the chi square value of 1.946 at df3 
(7.82) p(<0.05) shows no significance 
Regarding mucositis score and occupation the chi-square value of 1.270 at df1 
(3.84) p(<0.05) shows no significance. 
Regarding mucositis score and type of cancer the chisquare value of 7.3 at df 11 
(19.68) p(<0.05) shows no significance 
Regarding mucositis score and habits of betel nut, kutka, panmasala chewing and 
smoking  the chisquare  value of 0.42, 0.27, and o.351 at df 1 (3.84) p(<0.05) shows no 
significance 
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Regarding  the association between the oral mucositis score and habit of tobacco 
chewing the chi-square value of 8.722 at df (1)  P (>0.05) shows significance. 
Regarding the association between the usage of drugs and oral mucositis the chi 
square value shows significance of 8. 712 at df (2) at level of 0.05. 
  With regard to these demographic variables of tobacco chewing and chemo 
drugs used significant association is seen, between the pre test level of oral mucositis 
score, hence the research hypothesis is accepted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
64 
 
CHAPTER - V 
DISCUSSION 
Oral mucositis (OM) is a common symptom effect of radiation and chemotherapy. It is 
defined as an inflammation of oral mucosa resulting from cancer therapy typically manifesting as 
atrophy, swelling, erythema and ulceration (Sonis, 2004). 
It has a serious impact on those who are undergoing cancer treatment. It will affect 
treatment schedule by delay or discontinued treatment, quality of life and aspects of daily living 
(Brown, 2010).     
However, prevention and management of OM are challenging issues for health care 
professionals. Unfortunately, we are still unable to offer curative solutions to those patients who 
suffer from OM. 
Numerous methods have been tested to cope with this problem. This study was conducted 
to evaluate the effectiveness of flavored ice cubes in oral mucositis  among patients  with cancer 
receiving chemotherapy at Devaki Cancer and Research Centre, Madurai .  
The study consisted total of 60 samples, 30 in the experimental group and 30 in the 
control group. The design adopted for this study was pre-test post-test true experimental control 
group design. The tool used for study was oral mucositis assessment scale. 
The study findings are discussed in this  chapter with reference to the objectives and 
hypotheses as stated in chapter –I for the discussion to be effective some of the objectives are 
clubbed together. 
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DISTRIBUTION OF SAMPLES WITH REGARD TO DEMOGRAPHIC AND 
CLINICAL CHARACTERISTICS: 
The samples of the study included both males and females, in this study the number of 
males with cancer was high in both the groups (experimental-. 21(70%) and 16(53.33%) in 
control group). 
Majority of samples were between 51-60 years with, 11(36.67%)-in experimental group 
and 10(33.33%) in control group. Most of the samples in experimental group have undergone 
primary education (30%) and in control group most of the samples underwent secondary 
education (36.66%). With regard to occupation both in experimental group and control group the 
majority of the samples were employed with 20(66.66%) and 22(73.33%) respectively. Both in 
experimental group and control group majority of the samples were having lung cancer(26.66%) 
and (30%), stomach cancer 5(16.66%) and 5 (16.66%), cervical cancer 7(23.33%) and 
8(26.67%) . smoking is the major habit seen in the groups in 1/3rd (40%) in total than the other 
habits of beetel nut chewing, tobacco chewing, Kutka and Pan Masala chewing. 13% of samples 
had habit of smoking in experimental  group and  11% in control group.  
 THE FIRST OBJECTIVE OF THE STUDY IS TO DETERMINE THE  LEVEL OF 
MUCOSITIS IN PATIENTS WITH CANCER  RECEIVING  CHEMOTHERAPY  IN 
EXPERIMENTAL GROUPS BEFORE AND AFTER  USING FLAVORED ICE CUBES. 
  In this study, on day 1 pre test among the experimental group, 70% had mild ulceration 
and 86.66% had not severe erythema. On post test day 3, the 50% had mild ulceration and 70% 
had no erythema. On post test day 21, 73.33% had no ulceration and 60% had no erythema.                   
Heydari, Sharifi, Salek, (2012), described that, symptomatic relief from mouth pain can be 
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achieved by sucking ice chips when the chemotherapy drug is most concentrated in the body. 
This technique, called cryotherapy, works by decreasing blood flow to sores.  
   Baydar, Dilkitas, Sevine, Senel, and Aydogdu, (2005), studied the effects of local 
cryotherapy on mucositis incidence administrated during 5-FU treatment. Among  a total of 99 
courses, 5-FU and folinic acid combination chemotherapy was given to 40 patients. Cryotherapy 
was given to the same patient in one course but not given in the next.  Findings revealed that 
While mucositis developed in 6.7% of the courses given with cryotherapy, this ratio was 38.9% 
in courses given without cryotherapy. In the logistic regression analysis, development of 
mucositis had been found to correlate only with cryotherapy. Odds ratio (OR) = 11.5; in the 95% 
confidence interval (CI) = 3.2 - 41.9; (p = 0.001).  They concluded that oral cooling prevents 5-
FU induced mucositis. This effective prophylactic treatment should be used in patients who are 
at increased risk for developing 5-FU induced mucositis. 
THE SECOND OBJECTIVE IS TO DETERMINE THE PRE TEST AND POST TEST 
LEVEL OF ORAL MUCOSITIS AMONG PATIENTS WITH CANCER RECEIVING 
CHEMOTHERAPY IN CONTROL GROUP 
In control group, 73.33% had mild ulceration and 60% had not severe erythema.on post 
test day 3  90% had mild ulceration and 96.6% had not severe erythema.on day 21 70% had mild 
ulceration and 93.33% had not severe erythema. 
Herlofson, Norman-Pedersen , Redfors , Fosså ,  (1997), studied that cancer 
chemotherapy often leads to injury of normal cells. Adverse effects on oral mucosa have been 
documented for several cytotoxic treatment regimens. They conducted a retrospective study 
among 39 patients undergoing cisplatin based chemotherapy regimen. The patients were divided 
into two groups, a case group (24 individuals) having received 4 7 cycles of cisplatin-based 
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chemotherapy in addition to surgery, and a control group (15 individuals) treated with surgery 
alone. The study revealed that 62% of the patients in the chemotherapy group developed adverse 
soft tissue reactions, with mucositis and pain as chief complaints, whereas none in the control 
group experienced any mucosal complications. 
According to Bio Medical Centre of  Oral Health, (2006)., Oral mucositis (OM) is 
multifactorial in nature. The disruption or loss of rapidly dividing epithelial progenitor cells is a 
trigger for the onset of the disorder. However, the actual manifest dysfunction and its severity 
and duration are greatly influenced by changes in other cell populations, immune responses and 
the effects of oral flora. This toxicity frequently complicates the course of autologous bone 
marrow transplantation; it causes severe pain as well as cramping, nausea and gastro-enteritis. In 
addition, food and fluid intake may be poor, the ability to absorb nutrients much reduced and the 
susceptibility to infection greatly increased. The nature and degree of mucositis experienced by a 
patient varies according to the treatment regimen applied (combination of radiotherapy and 
chemotherapy, dosage, duration and sequence). Mucositis can therefore result in under-nutrition 
and significantly decreases a patient's quality of life. Modulation of the treatment regimen (use of 
lower doses or long recovery intervals between doses) remains the most effective means of 
limiting the actual incidence and severity. This event can therefore compromise patient 
prognosis. 
THE THIRD OBJECTIVE IS TO CHECK THE EFFECTIVENESS OF FLAVORED ICE 
CUBES ON MUCOSITIS AMONG PATIENTS WITH CANCER RECEIVING 
CHEMOTHERPAY 
 As per the table 9 shows that the mean post test score of oral mucositis in experimental 
group on day 3 was 1.13 which was lower than the mean post test score (3.8) of control group.  
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The obtained ‘t’ value of 8.6 was significant at 0.05 level.  As per the data on table 10, the mean 
post test score of oral mucositis in experimental group on day 21 was 0.76 which was lower than 
the mean post test score (2.50) of control group on day 21.  The obtained ‘t’ value of 0.58 is not 
significant at the level of 0.05.  The difference in the mean could be due to the effect of oral 
cryotherpay. 
  Cascinu, Fedeli, catalano, (1994)conducted   a randomised study that demonstrated the 
utility of oral cooling (cryotherapy) in the prevention of 5-fluorouracil (5FU)-induced stomatitis. 
In order to verify these results a confirmatory study, using identical treatment regimen, was 
initiated. 84 patients treated with a 5-FU-containing regimen were randomised to a control arm 
or to receive oral cryotherapy. End point evaluation was obtained by a global assessment of the 
physician's judgement and patients' description of mucositis severity graded 0–4. Mucositis was 
significantly reduced by cryotherapy considering both the first cycle of therapy (the mean 
toxicity score for cryotherapy was 0.59 and it was 1.1 for the control group, P>0.05) and all the 
chemotherapeutic courses (the mean toxicity score for cryotherapy was 0.36 when it was 0.69 for 
the control group, P>0.05). In conclusion, the present study confirms that cryotherapy can 
decrease 5FU-induced stomatitis and should be recommended for patients receiving bolus 5FU-
containing regimens.  
  RajeshLalla (2008)., it has been  hypothesized that topical administration of ice chips to 
the oral cavity during administration of chemotherapy results in decreased delivery of the 
chemotherapeutic agent to the oral mucosa. This effect is presumably mediated through local 
vasoconstriction and reduced blood flow. Several studies have demonstrated that cryotherapy 
reduces the severity of oral mucositis in patients receiving bolus doses of chemotherapeutic 
agents.   
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THE FOURTH OBJECTIVE IS TO FIND OUT THE ASSOCIATION BETWEEN THE 
PRETEST LEVELS OF MUCOSA AMONG PATIENTS WITH CANCER WITH 
SELECTED DEMOGRAPHIC VARIABLES.   
  The study findings  shows there is significant association between the oral mucositis and 
habit of tobacco chewing. The chi square value of 8.722 at df 1 p(>0.05) shows significance and 
the association between the level of oral mucositis and the treatment regimen followed the chi 
square valueof df 2 (8.712) shows significance at p(>0.05).   
According to oralcancerfoundtation.org, Oral mucositis is probably the most common, 
debilitating complication of cancer treatments, particularly chemotherapy and radiation. It can 
lead to several problems, including pain, nutritional problems as a result of inability to eat, and 
increased risk of infection due to open sores in the mucosa. It has a significant effect on the 
patient’s quality of life and can be dose-limiting (i.e., requiring a reduction in subsequent 
chemotherapy doses).Factor that can increase the likelihood of developing mucositis, or that can 
make it worse if it does occur, include habit of tobacco chewing. 
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CHAPTER - VI 
SUMMARY, CONCLUSION, IMPLICATIONS AND 
RECOMMENDATIONS 
According to Daniela Alterio et al (2007)The topical application of ice chips 
(cryotherapy) on the inflamed mucosa is based on the hypothesis that temporary local 
vasoconstriction of the oral mucosa vessels could reduce exposure of the replicating epithelium 
cells to peak levels of some cytostatic agents. 
This chapter presents the summary, major findings, conclusion, implications and 
recommendations of the study. 
SUMMARY  
 The aim of the study was to determine the effectiveness of oral cryotherapy in oral 
mucositis among patients with cancer receiving chemotherapy. 
The  objectives  of the study. 
  To determine the level of oral mucositis among patients with cancer receiving 
chemotherapy in experimental group before and after using  flavored ice cubes. 
 To determine the pre and post test level of oral mucositis among patients with cancer 
receiving chemotherapy in control group. 
 To check the effectiveness of flavored ice cubes on oral mucositis among patients with 
cancer receiving chemotherapy. 
 To find out the association between the pre test level of oral mucositis among patients 
receiving chemotherpay and selected demographic variable. 
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The following hypotheses were set for the study, and all hypotheses were tested at 0.05 level 
of significance 
 The mean post-test level of mucositis score among patients with cancer receiving 
chemotherapy will be significantly lower than their mean pre-test level of mucositis score 
in experimental group. 
 The mean post test level of mucositis score in experimental group of patients with cancer 
receiving chemotherapy will be significantly lesser than the mean post test score of 
patients  with cancer  receiving chemotherapy in control group. 
 There will be significant association between the pre test level of mucositis and 
demographic variables(age, sex, occupation, education, occupation, habits of smoking, 
tobacco chewing, Kutka and Panmasala chewing, type of cancer, chemo drugs used) 
MAJOR FINDINGS OF THE STUDY 
Demographic characteristics of the Samples 
 With regard to age, both in experimental group and  control group majority of samples 
were between 51-60 years ,11(36.67%) and 10(33.33%) respectively.  
 Regarding sex, in both experimental group and control group the majority of the samples 
were males. 21(70%) and 16(53.33%) respectively. 
 With regard to education both in experimental group and control group the majority of 
the samples were illiterate 10(33.33%) and 12 (40%) respectively. 
 Wit regard to occupation both in experimental group and control group the majority of 
the samples were employed 20(66.66%) and 22(73.33%) respectively. 
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 Regarding the type of cancer both in experimental group and control group majority of 
the samples were having lung cancer (26.66%) and (30%), stomach cancer 5(16.66%) 
and 5 (16.66%), cervical cancer 7(23.33%) and 8(26.67%) respectively. 
 Regarding the habit of tobacco chewing, majority of the samples in experimental group 
and control group had no habit of tobacco chewing 27(90%) and 29(96.6%) respectively. 
 With regard to habit of betel nut chewing both in experimental group and control group 
majority of the samples had no habit of betel nut chewing 28(93.33%) and 29(96.6%) 
respectively. 
 Regarding the habit of smoking majority of the samples  in experimental group and 
control group had no habit of smoking 17(56.66%) and 19(63.33%) respectively. 
 With regard to habit of kutka usage majority of the samples in experimental and control 
group shows no usage 30(100%) and 30(100%) respectively. 
 Regarding the habit of pan chewing both in experimental group and control group 
majority of the samples had no habit  of pan chewing 28(93.33%) and 29(96.66%) 
respectively. 
 In regard to drug usage of the samples in experimental group cisplatin + 5FU was used in 
23.3% of samples, cisplatin + Etoposide was used in 53.3% of the samples.  Other drugs 
like cisplatin + Paclitaxel, cisplatin + irinotecan, cisplatin + gemcitabine,  was used 
23.3% of samples.  In control group cisplatin + 5FU was used in 56.7% of samples.  
Cisplatin + etoposide was used in 20% of samples. Other drugs was used in 23.3% of 
samples. 
In experimental group, 21(70%)  had mild ulceration and 26(86.66%) had not severe 
erythema before the application of flavored ice cubes, whereas after the application of flavored 
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ice on 3rd day the subjects  15(50%) had no ulceration and 15(50%) had mild ulceration and 
21(70%)had no erythema and 9(30)had not severe erythema and on 21st day 22(73.33%) had no 
ulcer and 18(60%) had no erythema. 
In control group 22(73.3%) had mild ulceration and 18 (60%) had not severe erythema on 
pre-test whereas on 3rd post test day 27(90%) had mild ulceration and 29(96.66%) had not severe 
erythema and on 21st day 21(70%)had mild ulceration and 28(93.33%)had not severe erythema. 
In experimental group on 3rdday the subjects 15(50%) had no ulcer and 15(50%) had mild 
ulcer and 21(70%) had no erythema  and 9(30%) had not severe erythema  . In control group on 
3rd day the subjects 3(10%)had no ulcer and 27(90%)had mild ulcer and 1(3.33%)had no 
erythema and 29(96.67%)had not severe erythema . 
In experimental   group and control group on 21st day the subjects 22(73.33%) had no ulcer 
and 8(26.66%)had mild ulcer and 18(60%)had no erythema and 12(40%) had no erythema. In 
control group the subjects 9(30%)had no ulcer and 21(70%) had mild ulcer and  2(6.67%)had no 
erythema and 28(93.33%)had not severe erythema. 
Mean post test level of mucositis (1.13) after the application of flavored ice .cubes was 
lower than the mean pretest level of mucositis (2.76) before the use of ice cubes. The obtained t 
value is greater than the table value. This indicates that the application of ice cubes in oral 
mucositis is effective in reducing the oral mucositis. 
Mean post test level of  mucositis (0.76) after the application of flavored ice .cubes was 
lower than the mean pretest level of mucositis (2.76) before the use of ice cubes. The obtained t 
value is greater than the table value. This indicates that the application of ice cubes in oral 
mucositis is effective in reducing the oral mucositis. 
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Mean post test level of mucositis in experimental group (1.13) after the application of 
flavored ice cubes was lower than the mean post test level of mucositis in control group (3.8). 
The obtained t value is greater than the table value. This indicates that the application of ice 
cubes in oral mucositis is effective in reducing the oral mucositis 
Mean post test level of mucositis in experimental group (0.76) after the application of 
flavored ice cubes was lower than the mean post test level of mucositis in control group (2.50). 
The obtained t value is lesser  than the table value. This indicates that the application of ice cubes 
in oral mucositis is not effective in reducing the oral mucositis. 
There was a significant association between, chemodrug usage and severity of 
oralmucositis in cancer patients receiving chemotherapy. 
There was significant association between the level of oralmucositis and selected 
demographic variable – tobacco chewing. 
CONCLUSIONS 
The following conclusions were drawn from the study  
 Patients with cancer undergoing chemotherapy showed significant decrease in the 
level of mucositis after receiving   application of flavored ice cubes.. 
  The level of oral mucositis among patients with cancer on chemotherapy in 
experimental group shows significant decrease (0.76) after the application of 
flavored ice cubes than the pre test score (2.76), shows the effectiveness of 
application of flavored ice cubes. 
 The post test level of oral mucositis (2.36)  was lower than the pre test score 
(2.63) of oral mucositis in the control group. 
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 The study finding says that there is significant association between level of oral 
mucositis and habit of tobacco chewing. χ2 8.722   p(>0.05)  and the  chemo 
drugs used  χ2 (8.712)  p(>0.05).  
IMPLICATIONS 
This study has many implications in the field of nursing this includes nursing practice, 
nursing education, nursing research and nursing administration. 
NURSING PRACTICE 
 The findings of the study ensure that application of ice cubes for patients with cancer 
receiving chemotherapy reduces and prevents the damage of the oral mucosa. 
 Cryotherapy reduces the amount of drug reaching the oral mucous membrane and may 
therefore reduce the mucositis caused by the cytotoxic effects of the drugs. 
 A standard approach can be followed which includes a baseline of assessment consisting 
of risk assessment and oral inspection before any patients commences chemotherapy.. 
 This evidence based practice will enhance quality and standards of nursing care given to 
the patient in the management of oral mucositis. 
 Routine practice of this ice cube application prevents patient from getting acquired to 
infection and malnourishment, and improves the treatment compliance and quality of life 
of patients.  
 Cryotherapy is a simple, easy, well tolerated, non-expensive and safe method with 
limited side effects. It improves nursing performance and practice from symptom relief to 
symptom prevention of oral mucositis. 
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NURSING EDUCATION 
 Conducting Conferences for the staff nurses with a  focus on the best evidence on 
prevention and treatment of oral mucositis to increase the awareness and to  reduce 
dilemmas in the best method of prevention and treatment. 
 Conducting an awareness campaign about the risk factors associated with mucositis will 
allow nurses to identify cancer patients at greater risk and incorporate supportive care 
measures into their management plans 
NURSING RESEARCH 
 Research shall be done on the concept of effectiveness of oral cooling by the usage of 
cold water swishing, ice chips swishing in the reduction of oral mucositis. 
 Findings of the study will provide the base line data about the oral mucositis healing and 
it can be used for further studies in this area. 
 Investigating this intervention in other chemotherapy regimens with large sample size 
helps to generalise the findings. 
 Clinical trials shall be done in patients undergoing chemotherapy with few other drugs. 
NURSING ADMINISTRATION 
 Nurse administrators should prepare protocols for the effective usage of oral cryotherapy 
to practice in routine among the cancer patients receiving chemotherapy in clinical 
settings. 
 Nurse administrators shall enhance researchers to do clinicaltrials to broaden the potential 
applications of cryotherapy in clinical settings.  
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LIMITATIONS 
The study was done on small sample size of 60, hence generalizations is possible only for 
the selected populations in Devaki Cancer and Research Institue, Madurai during the data 
collection period. 
RECOMMENDATIONS 
 The study can be concluded using large populations to generalize the findings. 
 A longitudinal study can be conducted to assess the effectiveness of selected nursing 
intervention on reducing the chemotherapy induced oral mucositis. 
 Various techniques like ice chip and cold water swishing can be tried among similar 
samples 
 Randomized clinical trial cross over study shall be done to prove the effectiveness of oral 
cryotherapy using plain and flavored ice cubes in the reduction of oral mucositis. 
 Qualitative study can be conducted to study the effects of oral mucositis in the quality of 
life of patients undergoing chemotherapy. 
 Incidence of oral mucositis and its risk shall be assessed among cancer patients receiving 
chemotherapy. 
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APPENDIX – IV 
TOOL TO ASSESS THE LEVEL OF ORAL MUCOSITIS 
SECTION - I 
DEMOGRAPHIC DATA 
SAMPLE NO: 
1. Age  
2. Sex  
3. Education  
4. Occupation  
5. Habit of  
 Panmasala chewing: 
                                                      Yes/no 
 Tobacco chewing: 
                                                      Yes/no 
 Smoking: 
                                                      Yes/no 
 Betel nut chewing: 
                                                       Yes/no 
 Kutka chewing: 
                                                       yes/no: 
 
SECTION - II 
CLINICAL PROFILE: 
1. Type of cancer: 
2.  Chemo drugs used: 
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SECTION – III 
 
 
ORAL MUCOSITIS ASSESSMENT SCALE 
 
Location Ulceration 
Cm^2 
Score Pre 
Test 
Post 
test 
day 3 
Post test 
day 3 
Erythema 
 
Score Pre test 
day 1 
Post test 
Day 3 
Post test 
day 21 
Lip 
 
lower 
none 
<1cm 
1-3cm 
3cm 
0 
1 
2 
3 
   none 
not severe 
severe 
0 
1 
2 
 
   
 
upper 
none 
<1cm 
1-3cm 
3cm 
0 
1 
2 
3 
   none 
not severe 
severe 
0     
Buccal 
mucosa 
Right 
none 
<1cm 
1-3cm 
3cm 
0 
1 
2 
3 
   none 
not severe 
severe 
1     
 
Left  
none 
<1cm 
1-3cm 
3cm 
0 
1 
2 
3 
   0-none 
1-not 
severe 
2-severe 
2     
Tongue 
ventro 
lateral 
Right 
none 
<1cm 
1-3cm 
3cm 
0 
1 
2 
3 
   none 
not severe 
severe 
0     
 
Left  
none 
<1cm 
1-3cm 
3cm 
0 
1 
2 
3 
   none 
not severe 
severe 
1     
 
Floor of 
mouth 
none 
<1cm 
1-3cm 
3cm 
0 
1 
2 
3 
   none 
not severe 
severe 
2     
Palate 
  
soft 
none 
<1cm 
1-3cm 
3cm 
0 
1 
2 
3 
   none 
not severe 
severe 
 
0     
92 
 
  
INTERPRETATION: 
ULCERATION PRE TEST 
SCORE 
POST TEST 
SCORE 
ERYTHEMA PRE TEST 
SCORE 
POST TEST 
SCORE 
0-No 
ulcer 
1 – 9  
mild , 
10 – 18 – 
moderate, 
19 – 27 – 
severe  
 
 
 
 
 
 
 
  0 – No erythema 
1 – 9 – not 
severe  
10 – 18 severe 
erythema 
  
 
 
Hard  
none 
<1cm 
1-3cm 
3cm 
0 
1 
2 
3 
   none 
not severe 
severe 
0 
1 
2 
 
   
Score:           
